HeartBeat Technologies

Company Overview

Snapshot

Founded in November 2013 by Michael Kasan and Ehud Baron, HeartBeat Technologies operates with 1–10 employees. The company has raised $650,000 across four funding rounds from two investors. In March 2018, the company announced plans to test its health-care technology in Canada.

Business overview

HeartBeat Technologies (HBT) is a medical application software company that develops proprietary machine learning algorithms to generate real-time hemodynamic parameters. Its software integrates with third-party wearable devices to measure biometrics such as continuous blood pressure, cardiovascular indicators, and hydration. HBT offers a product suite of mobile applications, including MediBeat Pro, MediBeat, and Beatness, which analyze sensor data to display advanced hemodynamic parameters. The solution uploads session and patient information to a HIPAA and HL7 compliant server, providing a managed service for healthcare providers and individuals to monitor heart-related parameters and facilitate noninvasive care management. The company operates in the Digital Health and Medical Technologies sector, serving markets in the United States and Canada.

Strategic signal

In March 2018, HeartBeat Technologies announced its intention to test its health-care technology in Canada. This move signaled the company's strategic focus on market expansion and validation of its mobile application software in new geographic regions, indicating potential for broader adoption and regulatory approval in international markets.

Company Intelligence Q&A

What is HeartBeat Technologies' core offering?

HeartBeat Technologies develops mobile application software that uses proprietary machine learning algorithms to generate real-time hemodynamic parameters, integrating with wearable devices to monitor biometrics like continuous blood pressure and cardiovascular indicators.

When was HeartBeat Technologies founded and by whom?

HeartBeat Technologies was founded in November 2013 by Michael Kasan and Ehud Baron.

What was a significant market expansion initiative for HeartBeat Technologies?

In March 2018, HeartBeat Technologies announced that it would be testing its health-care technology in Canada, indicating an effort to expand its market reach and validate its solutions internationally.

What is the total capital raised by HeartBeat Technologies?

HeartBeat Technologies has raised a total of $650,000 across four funding rounds.

What is the status of HeartBeat Technologies?

HeartBeat Technologies is currently non-active, having ceased to operate in December 2025.